GlassScriptPhysician profile
Shaneka Gregory
NPI 1841835691
$837.55
in general payments reported to CMS, 2019-2025
11 companies · $18.32 in 2025
The $18.32 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $49.47 · 2023: $260 · 2024: $510 · 2025: $18.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $144.34 | 2023-2024 | Gemtesa |
| Astellas Pharma US INC | $121.70 | 2023 | Xtandi |
| Genmab U.S., INC. | $112.86 | 2023-2024 | Tivdak |
| Merck Sharp & Dohme LLC | $106.18 | 2023-2024 | Keytruda |
| Pfizer INC. | $81.26 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $74.47 | 2022-2024 | Lynparza |
| Photocure INC | $69.68 | 2024 | Cysview |
| Boston Scientific Corporation | $49.75 | 2023 | Upsylon |
| Urogen Pharma, INC. | $32.97 | 2024 | |
| Ferring Pharmaceuticals INC. | $23.05 | 2024 | Adstiladrin |
| Janssen Biotech, INC. | $21.29 | 2024 | Erleada, Balversa, Akeega |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaneka Gregory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.